Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Aratana Therapeutics Inc (PETX_old)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aratana Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Aratana Therapeutics historical data, for real-time data please try another search
4.92 0.00    0.00%
04/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 4.88 - 5.01
Aratana Therapeutics 4.92 0.00 0.00%

PETX_old Recent Sentiments

 
This page contains information on users’ sentiments for the Aratana Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 05, 2020 Andreas Schatz   4.92 Feb 28, 2020 @ 4.92 0.00%
May 21, 2019 davide garulli   4.88 Jun 14, 2019 @ 4.78 +2.05%
May 15, 2019 Lindsay   4.85 Jun 07, 2019 @ 4.87 -0.41%
May 09, 2019 Miguel Eloi   4.94 May 31, 2019 @ 4.63 -6.28%
Apr 26, 2019 Robbert Kuipers   4.75 May 17, 2019 @ 4.88 +2.74%
Apr 26, 2019 Robbert Kuipers   4.75 Apr 26, 2019 @ 4.75 0.00%
Apr 26, 2019 Aket Orem   4.70 May 17, 2019 @ 4.88 +3.83%
Apr 26, 2019 Zhahir Hassim   4.71 May 17, 2019 @ 4.88 -3.61%
Apr 26, 2019 davide garulli   4.69 May 17, 2019 @ 4.88 -4.05%
Apr 26, 2019 vbg99   3.43 Apr 26, 2019 @ 4.67 +36.15%
Apr 05, 2019 Carl Dexter Zamoras   3.94 Apr 26, 2019 @ 4.79 -21.57%
Mar 04, 2019 olga mohr   3.98 Mar 29, 2019 @ 3.60 +9.55%
Feb 26, 2019 Lindsay   4.12 Mar 22, 2019 @ 3.67 -10.92%
Feb 01, 2019 владимир рад   4.47 Mar 03, 2019 @ 4.05 -9.40%
Jan 15, 2019 Galaxybane   4.11 Feb 15, 2019 @ 6.43 +56.45%
Jan 15, 2019 Miguel Clos Uribe   4.00 Jan 18, 2019 @ 4.14 +3.50%
Jan 14, 2019 Sherwood Bailey   4.09 Feb 14, 2019 @ 6.43 -57.21%
Jan 11, 2019 Sergey Nazarov   4.17 Feb 11, 2019 @ 6.43 +54.20%
Jan 11, 2019 Ibrahim Alsalibi   4.27 Feb 11, 2019 @ 6.43 +50.59%
Jan 11, 2019 Alex Nobili   4.28 Jan 11, 2019 @ 4.39 +2.57%
Jan 11, 2019 olga mohr   4.29 Feb 11, 2019 @ 6.43 +49.88%
Jan 11, 2019 Mich Capovilla   4.30 Jan 24, 2019 @ 4.26 +0.93%
Jan 11, 2019 bharat ahuja   4.29 Feb 11, 2019 @ 6.43 -49.88%
Jan 11, 2019 Gianluca Principe   4.31 Feb 11, 2019 @ 6.43 +49.19%
Jan 11, 2019 Inversiones Diserven   4.23 Feb 11, 2019 @ 6.43 +52.01%
Dec 10, 2018 Lindsay   6.43 Jan 09, 2019 @ 6.43 0.00%
Nov 09, 2018 Lindsay   6.67 Dec 09, 2018 @ 6.43 -3.60%
Aug 28, 2018 Lindsay   5.29 Sep 27, 2018 @ 5.80 +9.64%
Aug 15, 2018 Richard Nerat   4.96 Sep 14, 2018 @ 5.34 +7.66%
Jul 26, 2018 Lindsay   4.44 Aug 25, 2018 @ 5.32 +19.82%
Mar 16, 2018 John Odonoghue   4.03 Apr 15, 2018 @ 5.05 -25.31%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PETX_old Comments

Write your thoughts about Aratana Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lindsay Marcus
Lindsay Nov 09, 2018 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bullish on PETX. Dog pharma stats are remarkable.  Aratana is the perfect take-over candidate.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email